Wyeth shareholders to decide Pfizer merger at meeting on July 20

By Lisa Kerner

Charlotte, N.C., June 17 - Wyeth will ask its shareholders to approve the company's merger with Pfizer Inc. at a special meeting at 9 a.m. ET on July 20 in Morristown, N.J.

The record date for the meeting is June 5, according to a form 424B3 filed with the Securities and Exchange Commission.

In January, the pharmaceutical giants agreed to combine in a cash-and-stock deal valued at $50.19 per share, or a total of approximately $68 billion.

Each outstanding share of Wyeth common stock will be converted into the right to receive $33.00 in cash and 0.985 of a share of Pfizer common stock, the filing said.

Wyeth will become a wholly owned subsidiary of New York-based Pfizer.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.